Drugs / VRC-HIVAAV070-00-GT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03374202 | Jan 2018 → Aug 2026 overdue | — | National Institute of Allergy and Infectious Diseases (NIAID) | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-HIVAAV070-00-GT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03374202 ↗ |
| Known as | AAV8-VRC07 | “VRC-HIVAAV070-00-GT (AAV8-VRC07)” NCT03374202 ↗ |
| Route | Intramuscular | “All injections were administered intramuscularly (IM) by needle and syringe.” NCT03374202 ↗ |